Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Warts 2Melanoma 2Hyperthermia 2Uterine Cervical Neoplasms 1Tuberous Sclerosis 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Seizures 1Sarcoma 1Prostatic Neoplasms 1Ovarian Neoplasms 1Metastatic Castration-resistant Prostate Cancer (mCRPC) 1Lymphoma, T-Cell 1Lennox Gastaut Syndrome 1Hemorrhage 1Hematologic Neoplasms 1Epilepsies, Myoclonic 1Carcinoma, Transitional Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Brain Neoplasms 1

Interventions

Sirolimus 2exemestane 1Solutions 1Sertraline 1Selective Serotonin Reuptake Inhibitors 1Phlebotomy 1Injections 1Genetic Testing 1Everolimus 1Cannabidiol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Tuberous Sclerosis × Solutions × Clear all
NCT05485831 2026-02-17

EpiTALY

Jazz Pharmaceuticals

Recruiting
100 enrolled

Epilepsies, Myoclonic, Seizures, Tuberous Sclerosis, Lennox Gastaut Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡